Compared with DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...

Several studies have shown a noticeable spike in the number of kidney stone cases during the summer months. Know if you are ...